Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
MAMMALIAN GENETIC MODELS WITH MINIMAL OR COMPLEX PHENOTYPES

Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy

Markos Leggas, Masashi Adachi, George L. Scheffer, Daxi Sun, Peter Wielinga, Guoqing Du, Kelly E. Mercer, Yanli Zhuang, John C. Panetta, Brad Johnston, Rik J. Scheper, Clinton F. Stewart, John D. Schuetz
Markos Leggas
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masashi Adachi
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George L. Scheffer
2Department of Pathology, VU Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daxi Sun
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Wielinga
3Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guoqing Du
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly E. Mercer
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanli Zhuang
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C. Panetta
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brad Johnston
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rik J. Scheper
2Department of Pathology, VU Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clinton F. Stewart
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John D. Schuetz
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: John.schuetz@stjude.org
DOI: 10.1128/MCB.24.17.7612-7621.2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Targeted disruption of the Mrp4 locus causes loss of renal Mrp4 expression. (a) Targeting construct design and locus. Xho, XhoI cleavage site; B, BamHI cleavage site; E, EcoRI cleavage site; Sal, SalI cleavage site; neo, position of neomycin phosphotransferase gene; TGA, stop codons engineered into exon 27 (see text). Exon numbers are shown. (b) Representative Mrp4 genotype analysis of Mrp4 wild-type, heterozygous, and nullizygous mice. (c) Immunoblot with anti-mouse Mrp4 shows Mrp4 expression in kidney membranes from Mrp4+/+ and Mrp4+/− but not Mrp4−/− mice. (d) Immunohistochemical analysis of Mrp4 expression in paraffin-embedded kidneys from Mrp4+/+ and Mrp4−/− mice. The murine anti-Mrp4 polyclonal antiserum Mrp4-mp was used in panels 1 and 2. The monoclonal anti-Mrp4 antibody M4I-10 was used in panels 3 and 5. The inset (panel 4) shows the proximal tubules at greater magnification.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Topotecan is an Mrp4 substrate. (a) Transport of the Mrp4 substrate estradiol-17β-glucuronide into membrane vesicles prepared from Saos-2 cells engineered to express Mrp4 (13) in the presence of various concentrations of topotecan. (b) The intracellular accumulation of topotecan was assayed in Saos-2 cells transfected with empty vector or stably expressing human MRP4 at the indicated times after treatment. (c) Topotecan sensitivity of the cells shown in panel d, shown as percent cell viability. Localization of Mrp4 in Saos-2 cells stably expressing Mrp4 (d) or transfected with empty vector (e). Bars represent 1 standard deviation.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Topotecan concentration in the brain is higher in the absence of Mrp4. (a) Mean (± standard deviation) concentration of topotecan in the brains of six Mrp4−/− (open bars) and six Mrp4+/+ (solid bars) mice 15 min and 6 h after intravenous injection of 2 mg of topotecan/kg. (b) Equal samples of total brain protein (10 μg) from Mrp4+/+ and Mrp4−/− animals were fractionated by polyacrylamide gel electrophoresis and treated with the monoclonal anti-Mrp4 antibody M4I-10.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Mrp4 is highly expressed in the basolateral membrane of the choroid plexus in multiple species. (a) Detection of Mrp4 in the choroid plexus (CP) and kidney of Mrp4+/+ mice by immunoblot analysis with two different anti-Mrp4 antibodies. 3T3, NIH 3T3 cells transfected with the Mrp4 expression vector or empty vector served as positive and negative controls, respectively. (b) Mrp4 was more abundant in the choroid plexus than in the kidney of Mrp4+/+ mice, as shown by immunoblot analysis with polyclonal anti-mouse Mrp4 (Mrp4-mp). (c) Immunohistochemical localization of Mrp4 in choroid plexus epithelial cells from Mrp4+/+ , Mrp4 +/− , and Mrp4−/− animals with the murine polyclonal Mrp4 antiserum (Mrp4-mp). The magnification is indicated above each panel. (d) Mrp4 expression detected in the choroid plexus from an FVB mouse, rat, and human (panels 1 to 4, respectively) with the anti-Mrp4 monoclonal antibody (M4I-10).

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Mrp4 is expressed in brain capillaries. (a) Frozen tissue sections prepared from the brains of Mrp4+/+ and Mrp4−/− FVB mice were treated with anti-Mrp4 monoclonal antibody. (b) Panel 1 shows a cross-section of wild-type mouse capillary, revealing red blood cells (asterisk), surrounding capillary wall, and luminal Mrp4 staining (red); panel 2 shows a rat capillary, revealing interior red blood cells (asterisk). Arrows indicate the capillary wall and the luminal endothelial cell Mrp4 staining (red). Magnifications are indicated to the left of the panels.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Expression of Mrp4 in choroid plexus epithelium restricts the CSF uptake of systemically administered topotecan. (a) CSF concentration of topotecan in Mrp4+/+ (solid circles) and Mrp4−/− (open circles) mice at the indicated times after intravenous injection of 2 mg of topotecan/kg. (b, left) Model showing the role of Mrp4 in the basolateral choroid plexus in restricting topotecan (TPT) penetration into the CSF. BCB, blood-CSF barrier. (b, right) Model depicting the role of Mrp4 in capillary endothelial cells in restricting penetration of topotecan into the brain. BBB, blood-brain barrier.

PreviousNext
Back to top
Download PDF
Citation Tools
Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy
Markos Leggas, Masashi Adachi, George L. Scheffer, Daxi Sun, Peter Wielinga, Guoqing Du, Kelly E. Mercer, Yanli Zhuang, John C. Panetta, Brad Johnston, Rik J. Scheper, Clinton F. Stewart, John D. Schuetz
Molecular and Cellular Biology Aug 2004, 24 (17) 7612-7621; DOI: 10.1128/MCB.24.17.7612-7621.2004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy
Markos Leggas, Masashi Adachi, George L. Scheffer, Daxi Sun, Peter Wielinga, Guoqing Du, Kelly E. Mercer, Yanli Zhuang, John C. Panetta, Brad Johnston, Rik J. Scheper, Clinton F. Stewart, John D. Schuetz
Molecular and Cellular Biology Aug 2004, 24 (17) 7612-7621; DOI: 10.1128/MCB.24.17.7612-7621.2004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Antineoplastic Agents
brain
Multidrug Resistance-Associated Proteins
Topotecan

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549